| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/07/2004 | EP1405665A1 Particle embedded with chemical substances and method of producing a particle |
| 04/07/2004 | EP1405646A2 Pharmaceutically acceptable salts of local anaesthetics with anti-inflammatory compounds and methods for preparing the same |
| 04/07/2004 | EP1405635A1 Functional grain-containing preparations quickly disintegrated in the oral cavity |
| 04/07/2004 | EP1405634A1 Cleansing article and cosmetic use thereof |
| 04/07/2004 | EP1405621A1 Method of manufacturing tablet |
| 04/07/2004 | EP1405046A1 Fluid delivery device having a water generating electrochemical/chemical pump and associated method |
| 04/07/2004 | EP1404860A2 Delivery system for nucleic acids |
| 04/07/2004 | EP1404841A2 Cyp1b1 nucleic acids and methods of use |
| 04/07/2004 | EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 04/07/2004 | EP1404516A2 Microencapsulation of drugs by solvent exchange |
| 04/07/2004 | EP1404398A1 Antibiotic drug delivery system |
| 04/07/2004 | EP1404397A1 Antibiotic drug delivery system |
| 04/07/2004 | EP1404386A2 Polymeric corneal bandages / lenses for delivery of a pharmaceutical |
| 04/07/2004 | EP1404372A1 Pharmaceutical formulations and ligands for use therein; mimetics for uea-1 |
| 04/07/2004 | EP1404369A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 04/07/2004 | EP1404363A2 Adjuvant composition for mucosal and injection delivered vaccines |
| 04/07/2004 | EP1404357A1 Gonadotropin releasing hormone antagonists in gel-forming concentrations |
| 04/07/2004 | EP1404351A1 Carbohydrate modifying agent and drinks containing the modifying agent |
| 04/07/2004 | EP1404345A2 Skin-permeable selective cyclooxygenase-2 inhibitor composition |
| 04/07/2004 | EP1404343A2 Therapeutic combinations for the treatment of hormone deficiencies |
| 04/07/2004 | EP1404341A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 04/07/2004 | EP1404336A1 Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis |
| 04/07/2004 | EP1404333A1 Oxymorphone controlled release formulations |
| 04/07/2004 | EP1404332A1 Methods of making sustained release formulations of oxymorphone related applications |
| 04/07/2004 | EP1404331A1 Sustained release formulations of oxymorphone |
| 04/07/2004 | EP1404324A2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/07/2004 | EP1404314A1 Aerosol formulations of delta 8 tetrahydrocannabinol |
| 04/07/2004 | EP1404310A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 04/07/2004 | EP1404306A1 A coated nicotine-containing chewing gum, manufacture and use thereof |
| 04/07/2004 | EP1404305A1 Pharmacological preparation made from a nanoparticulate mesomorphous polyelectrolyte lipid complex and at least one active ingredient |
| 04/07/2004 | EP1404304A1 Tablet comprising cetirizine and pseudoephedrine |
| 04/07/2004 | EP1404303A1 Stable pharmaceutical compositions containing pravastatin |
| 04/07/2004 | EP1404302A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 04/07/2004 | EP1404301A2 Stable controlled release pharmaceutical compositions containing pravastatin |
| 04/07/2004 | EP1404300A1 Pharmaceutical compositions of dispersions of drugs and neutral polymers |
| 04/07/2004 | EP1404299A2 Particles for inhalation having rapid release properties |
| 04/07/2004 | EP1404298A2 A method for preparation of vesicles loaded with biological material and different uses thereof |
| 04/07/2004 | EP1404296A2 Effervescent formulations of non-steroidal anti-inflammatory drugs |
| 04/07/2004 | EP1404295A2 Sustained release drug delivery devices with coated drug cores |
| 04/07/2004 | EP1404294A2 Biodegradable polymer composition |
| 04/07/2004 | EP1404291A1 Water-free ubichinon concentrate |
| 04/07/2004 | EP1404281A1 Pharmaceutical compositions of topic use, applied in treatment of skin and/or mucous injuries; use of compositions in treatment of skin and/or mucous injuries and use of compounds in treatment of skin and/or mucous injuries |
| 04/07/2004 | EP1404264A2 Insert for the treatment of dry eye |
| 04/07/2004 | EP1404174A2 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/07/2004 | EP1303267B1 Dermal for amino laevulinic acid |
| 04/07/2004 | EP1296662B1 Dermal therapeutic system containing 2-(3-benzophenyl)-propionic acid or '0-(2,6-dichloranilino)-phenyl!-ethanoic acid |
| 04/07/2004 | EP1294412A4 Method of using lectins for contraception and prophylaxis agains t diseases transmittable by sexual contact and condom containing lectins |
| 04/07/2004 | EP1220699B1 Medicament pack |
| 04/07/2004 | EP1183043B1 Medicament for localised application, containing fibrinogen, thrombin, transglutaminases and proteinase inhibitors |
| 04/07/2004 | EP1158964B1 Edible coating composition |
| 04/07/2004 | EP1156806B1 Pharmaceutical composition containing proton pump inhibitors |
| 04/07/2004 | EP1147148A4 Dextran-maleic acid monoesters and hydrogels based thereon |
| 04/07/2004 | EP1128820B1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 04/07/2004 | EP1105123B1 Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 04/07/2004 | EP1105108A4 Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
| 04/07/2004 | EP1089970B1 Oxidation inhibitors for prostane derivatives |
| 04/07/2004 | EP1086077B1 Novel antiestrogens, a method for the production thereof, and their pharmaceutical application |
| 04/07/2004 | EP1085907B1 Solution comprising prostaglandins and benzyl alcohol |
| 04/07/2004 | EP1014955B1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof |
| 04/07/2004 | EP0973509B1 Multiparticulate pharmaceutical form, particles constituting it, method and plant for making same |
| 04/07/2004 | EP0971687B1 Aqueous solutions of salicylic acid derivatives |
| 04/07/2004 | EP0954289A4 Disinfectant effervescent tablet formulation |
| 04/07/2004 | EP0870497B1 Aerosol preparation |
| 04/07/2004 | EP0836511B1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 04/07/2004 | EP0791037B1 Process for stabilizing gelatin products |
| 04/07/2004 | EP0789561B1 Oral cyclosporin formulations |
| 04/07/2004 | EP0731812B1 METHOD FOR ISOLATING POLY-beta-1-4-N-ACETYLGLUCOSAMINE |
| 04/07/2004 | EP0596032B2 Induction of cytotoxic t-lymphocyte responses |
| 04/07/2004 | CN1487967A A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 04/07/2004 | CN1487936A Medicinal compositions having improved absorbability |
| 04/07/2004 | CN1487935A Medicinal compositions improved in solubility in water |
| 04/07/2004 | CN1487854A Dehydrating agent and method for dehyclrating moist article using the agent and dehydrated article obtained by the method |
| 04/07/2004 | CN1487843A A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 04/07/2004 | CN1487837A Novel mixtures of microbial enzymes |
| 04/07/2004 | CN1487833A Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 04/07/2004 | CN1487832A Novel method and compositions for local treatment of Meniere's disease, tinnitus and lor hearing loss |
| 04/07/2004 | CN1487829A Chewing gums and related products that provide breath freshening characteristics |
| 04/07/2004 | CN1487828A New film coating |
| 04/07/2004 | CN1487827A Process for preparing non-hygroscopic sodium valproate composition |
| 04/07/2004 | CN1487825A Process for preparing particles |
| 04/07/2004 | CN1487258A Spray drying & granulating method and apparatus |
| 04/07/2004 | CN1486906A Package method for medicine powder for injection |
| 04/07/2004 | CN1486744A Application of neutral proteinase in preparing medicine for anorectal diseases and the medicine |
| 04/07/2004 | CN1486743A Chinese medicine injection and its production process |
| 04/07/2004 | CN1486742A Capsule prepn for regulating blood fat and blood sugar |
| 04/07/2004 | CN1486740A Chinese medicine composition for treating cancer |
| 04/07/2004 | CN1486739A Chinese medicine composition for treating apoplexy |
| 04/07/2004 | CN1486737A Hepatosis treating Chinese medicine with four integrated functions |
| 04/07/2004 | CN1486736A Fibrillation-resisting liver softening bolus as compound Chinese medicine prepn for treating fibrillation and cirthosis of liver |
| 04/07/2004 | CN1486735A Liver strengthening and protecting bolus as compound Chinese medicine for treating asthenia syndrome of hepatitis B |
| 04/07/2004 | CN1486734A Tumor eliminating capsule |
| 04/07/2004 | CN1486732A Hypoglycemic oral liquid prepn and its production process |
| 04/07/2004 | CN1486729A Medicine for treating and preventing hypertenston and hyperlipemia and its prepn |
| 04/07/2004 | CN1486726A Liquid medicine for treating psoriasis and its prepn |
| 04/07/2004 | CN1486724A Chinese medicine for treating diabetes |
| 04/07/2004 | CN1486718A Chinese medicine for delaying senility and the prepn process of the granule |
| 04/07/2004 | CN1486717A Chinese medicine for invigorating vital energy and benefiting kidney and the prepn process of the granule |
| 04/07/2004 | CN1486716A Chinese medicine for treating leukoderma and the prepn process of the tablets |
| 04/07/2004 | CN1486715A Ginkgo leaf powder for injection and its prepn |
| 04/07/2004 | CN1486712A Extractive of Chinese medicinal material rabdosia as antitumor medicine and its prepn process |